Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 147 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
R. Ryan and Majeed, A., “Prevalence of ischaemic heart disease and its management with statins and aspirin in general practice in England and Wales, 1994 and 1998”, Health Statistics Quartely, vol. 12, pp. 34-39, 2001.
R. Ryan and Majeed, A., “Prevalence of treated hypertension in general practice in England and Wales, 1994 to 1998.”, Health Stat Q, pp. 14-8, 2002.
R. Ryan, Newnham, A., Khunti, K., and Majeed, A., “New cases of diabetes mellitus in England and Wales, 1994-1998: database study”, Public Health, vol. 119, pp. 892-9, 2005.
J. M. Ryan, Peterson, M. D., Ryan, N., Smith, K. J., N, E. O. 'Connell, Liverani, S., Anokye, N., Victor, C., and Allen, E., “Mortality due to cardiovascular disease, respiratory disease, and cancer in adults with cerebral palsy”, Dev Med Child Neurol, 2019.
J. M. Ryan, Peterson, M. D., Matthews, A., Ryan, N., Smith, K. J., O'Connell, N. E., Liverani, S., Anokye, N., Victor, C., and Allen, E., “Noncommunicable disease among adults with cerebral palsy: A matched cohort study”, Neurology, 2019.
C. J. Ruzafa, Paczkowski, R., Boye, K. S., Di Tanna, G. L., Sheetz, M. J., Donaldson, R., Breyer, M. D., Neasham, D., and Voelker, J. R., “Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study”, Int J Clin Pract, vol. 69, pp. 871-82, 2015.
S. Russmann, Kaye, J. A., Jick, S. S., and Jick, H., “Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database”, Br J Clin Pharmacol, vol. 60, pp. 76-82, 2005.
A. Ruigomez, Brauer, R., Rodriguez, L. A., Huerta, C., Requena, G., Gil, M., de Abajo, F., Downey, G., Bate, A., Tepie, M. F., de Groot, M., Schlienger, R., Reynolds, R., and Klungel, O., “Ascertainment of acute liver injury in two European primary care databases”, Eur J Clin Pharmacol, vol. 70, pp. 1227-35, 2014.
A. Ruigomez, Rodriguez, L. A. Garcia, Cattaruzzi, C., Troncon, M. G., Agostinis, L., Wallander, M. A., and Johansson, S., “Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes”, Am J Epidemiol, vol. 150, pp. 476-81, 1999.
A. Ruigomez, Wallander, M. A., Johansson, S., and Rodriguez, L. A. Garcia, “One-year follow-up of newly diagnosed irritable bowel syndrome patients”, Aliment Pharmacol Ther, vol. 13, pp. 1097-102, 1999.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Gender and drug treatment as determinants of mortality in a cohort of heart failure patients”, Eur J Epidemiol, vol. 17, pp. 329-35, 2001.
A. Ruigomez, Rodriguez, L. A. Garcia, Dev, V. J., Arellano, F., and Raniwala, J., “Are schizophrenia or antipsychotic drugs a risk factor for cataracts?”, Epidemiology, vol. 11, pp. 620-3, 2000.
A. Ruigomez, Rodriguez, L. A. Garcia, Hasselgren, G., Johansson, S., and Wallander, M. A., “Overall mortality among patients surviving an episode of peptic ulcer bleeding”, J Epidemiol Community Health, vol. 54, pp. 130-3, 2000.
A. Ruigomez, Masso-Gonzalez, E. L., Johansson, S., Wallander, M. A., and Garcia-Rodriguez, L. A., “Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality”, Br J Gen Pract, vol. 59, pp. e78-86, 2009.
A. Ruigomez, Wallander, M. A., Johansson, S., and Rodriguez, L. A., “Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link?”, Dig Dis Sci, vol. 54, pp. 1079-86, 2009.
A. Ruigomez, Rodriguez, L. A. Garcia, Johansson, S., Wallander, M. A., and Edvardsson, N., “Risk of cerebrovascular accident after a first diagnosis of atrial fibrillation”, Clin Cardiol, vol. 30, pp. 624-8, 2007.
A. Ruigomez, Rodriguez, L. A., Wallander, M. A., Johansson, S., and Dent, J., “Endoscopic findings in a cohort of newly diagnosed gastroesophageal reflux disease patients registered in a UK primary care database”, Dis Esophagus, vol. 20, pp. 504-9, 2007.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK”, BMC Cardiovasc Disord, vol. 5, p. 20, 2005.
A. Ruigomez, Rodriguez, L. A., Wallander, M. A., Johansson, S., Thomas, M., and Price, D., “Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice”, Chest, vol. 128, pp. 85-93, 2005.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., and Dent, J., “Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care”, Curr Med Res Opin, vol. 22, pp. 1661-8, 2006.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., and Eklund, S., “Esophageal stricture: incidence, treatment patterns, and recurrence rate”, Am J Gastroenterol, vol. 101, pp. 2685-92, 2006.
A. Ruigomez, Rodriguez, L. A., Wallander, M. A., Johansson, S., and Jones, R., “Chest pain in general practice: incidence, comorbidity and mortality”, Fam Pract, vol. 23, pp. 167-74, 2006.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., Graffner, H., and Dent, J., “Natural history of gastro-oesophageal reflux disease diagnosed in general practice”, Aliment Pharmacol Ther, vol. 20, pp. 751-60, 2004.
A. Ruigomez, Rodriguez, L. A. Garcia, Johansson, S., and Wallander, M. A., “Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome?”, Maturitas, vol. 44, pp. 133-40, 2003.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation”, BMC Cardiovasc Disord, vol. 2, p. 5, 2002.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A., “Incidence of chronic atrial fibrillation in general practice and its treatment pattern”, J Clin Epidemiol, vol. 55, pp. 358-63, 2002.
A. Ruigomez and Rodriguez, L. A. Garcia, “Presence of diabetes related complication at the time of NIDDM diagnosis: an important prognostic factor”, Eur J Epidemiol, vol. 14, pp. 439-45, 1998.
C. Rudisill, Charlton, J., Booth, H. P., and Gulliford, M. C., “Are healthcare costs from obesity associated with body mass index, comorbidity or depression? Cohort study using electronic health records”, Clin Obes, vol. 6, pp. 225-31, 2016.
A. Rubino, Roskell, N., Tennis, P., Mines, D., Weich, S., and Andrews, E., “Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study”, Bmj, vol. 334, p. 242, 2007.
J. G. Royle, Lanyon, P. C., Grainge, M. J., Abhishek, A., and Pearce, F. A., “Correction to: The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink”, Clin Rheumatol, vol. 37, p. 2601, 2018.
J. G. Royle, Lanyon, P. C., Grainge, M. J., Abhishek, A., and Pearce, F. A., “The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink”, Clin Rheumatol, vol. 37, pp. 2103-2111, 2018.
S. Rowlands, Devalia, H., and Lawrenson, R., “Preferential prescribing of type of combined oral contraceptive pill by general practitioners to teenagers with acne”, Eur J Contracept Reprod Health Care, vol. 6, pp. 9-13, 2001.
S. Rowlands, Devalia, H., and Lawrenson, R., “Use of the combined oral contraceptive pill by under 16s”, J Fam Plann Reprod Health Care, vol. 27, pp. 17-9, 2001.
S. Rowlands, Devalia, H., Smith, C., Hubbard, R., and Dean, A., “Otitis externa in UK general practice: a survey using the UK General Practice Research Database”, Br J Gen Pract, vol. 51, pp. 533-8, 2001.
S. Rowlands, Devalia, H., Lawrenson, R., Logie, J., and Ineichen, B., “Repeated use of hormonal emergency contraception by younger women in the UK”, Br J Fam Plann, vol. 26, pp. 138-43, 2000.
S. Rowlands, Hooper, R., Hughes, R., and Burney, P., “The epidemiology and treatment of Bell's palsy in the UK”, Eur J Neurol, vol. 9, pp. 63-7, 2002.
S. Rowlands and Moser, K., “Consultation rates from the general practice research database”, Br J Gen Pract, vol. 52, pp. 658-60, 2002.
S. Rowlands and Hannaford, P., “The incidence of sterilisation in the UK”, Bjog, vol. 110, pp. 819-24, 2003.
M. Roughley, Sultan, A. A., Clarson, L., Muller, S., Whittle, R., Belcher, J., Mallen, C. D., and Roddy, E., “Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study”, Arthritis Res Ther, vol. 20, p. 243, 2018.
K. J. Rothnie, Smeeth, L., Herrett, E., Pearce, N., Hemingway, H., Wedzicha, J., Timmis, A., and Quint, J. K., “Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease”, Heart, vol. 101, pp. 1103-10, 2015.
K. J. Rothnie, Chandan, J. S., Goss, H. G., Mullerova, H., and Quint, J. K., “Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care”, Int J Chron Obstruct Pulmon Dis, vol. 12, pp. 1663-1668, 2017.
K. J. Rothnie, Mullerova, H., Hurst, J. R., Smeeth, L., Davis, K., Thomas, S. L., and Quint, J. K., “Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records”, PLoS One, vol. 11, p. e0151357, 2016.
K. J. Rothnie, Mullerova, H., Thomas, S. L., Chandan, J. S., Smeeth, L., Hurst, J. R., Davis, K., and Quint, J. K., “Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records”, Clin Epidemiol, vol. 8, pp. 771-782, 2016.
K. J. Rothnie, Connell, O., Mullerova, H., Smeeth, L., Pearce, N., Douglas, I., and Quint, J. K., “Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease”, Ann Am Thorac Soc, vol. 15, pp. 935-946, 2018.
K. J. Rothnie, Mullerova, H., Smeeth, L., and Quint, J. K., “Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease”, Am J Respir Crit Care Med, vol. 198, pp. 464-471, 2018.
D. Rothenbacher, Primatesta, P., Ferreira, A., Cea-Soriano, L., and Rodriguez, L. A., “Frequency and risk factors of gout flares in a large population-based cohort of incident gout”, Rheumatology (Oxford), vol. 50, pp. 973-81, 2011.
A. A. Root, Wong, A. Y., Ghebremichael-Weldeselassie, Y., Smeeth, L., Bhaskaran, K., Evans, S. J., Brauer, R., Wong, I. C., Navaratnam, V., and Douglas, I., “Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs”, Br J Clin Pharmacol, vol. 82, pp. 512-21, 2016.
A. Root, Brown, J. P., Forbes, H. J., Bhaskaran, K., Hayes, J., Smeeth, L., and Douglas, I. J., “Association of Relative Age in the School Year With Diagnosis of Intellectual Disability, Attention-Deficit/Hyperactivity Disorder, and Depression”, JAMA Pediatr, 2019.
G. Ronquist, Rodriguez, L. A., Ruigomez, A., Johansson, S., Wallander, M. A., Frithz, G., and Svardsudd, K., “Association between captopril, other antihypertensive drugs and risk of prostate cancer”, Prostate, vol. 58, pp. 50-6, 2004.
S. J. Ronaldson, Raghunath, A., Torgerson, D. J., and Van Staa, T., “Cost-effectiveness of antibiotics for COPD management: observational analysis using CPRD data”, ERJ Open Res, vol. 3, 2017.
[Page last reviewed 4 October 2019]